Reducing Post-Hospital Mortality in HIV-infected Adults in Tanzania

NCT ID: NCT03858998

Last Updated: 2025-04-23

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

500 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-03-05

Study Completion Date

2024-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This research is being done to assess the efficacy of a case management intervention to improve the one year mortality rate of hospitalized, HIV-infected, Tanzanian adults.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This research is being done to assess the efficacy of a case management intervention to improve the one year mortality rate of hospitalized, HIV-infected, Tanzanian adults. The study is being conducted at hospitals in Mwanza, Tanzania. 500 participants will be enrolled: 250 will be randomized to the case management intervention and 250 will randomized to routine clinical care. The case management intervention consists of 5 sessions over 90 days, and is designed to link hospitalized, HIV-infected patients to long term care at an HIV clinic. Participants will be followed for two years in order to evaluate primary and secondary study objectives.

Secondary outcome measures time frames have been updated to add the 24-month time point for consistency with the pre-specified endpoints in the study protocol.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV Infections

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Case Management Intervention

A 90-day case management intervention to link hospitalized HIV-infected participants with local HIV clinics.

Group Type EXPERIMENTAL

Case Management Intervention

Intervention Type OTHER

A 90-day case management intervention to link hospitalized HIV-infected participants with local HIV clinics.

Control

Intervention Type OTHER

Current routine HIV care in Tanzania.

Control

Current routine HIV care in Tanzania.

Group Type OTHER

Control

Intervention Type OTHER

Current routine HIV care in Tanzania.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Case Management Intervention

A 90-day case management intervention to link hospitalized HIV-infected participants with local HIV clinics.

Intervention Type OTHER

Control

Current routine HIV care in Tanzania.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years of age or older
* HIV-infected
* ART (anti-retroviral therapy) naïve or have been on ART but have not used ART for \> 7 days
* Lives in the region of Mwanza
* Able to be referred to an HIV clinic inside the region of Mwanza
* Has mobile phone or access to mobile phone
* Planning to stay in the region of Mwanza for the next 24 months
* Able to speak Kiswahili or English
* Capable and willing to provide informed consent
* Willing to provide locator information and two designated contact persons
* Willing to have a home visits from a study team member

Exclusion Criteria

* Pregnant
* On anti-retrovirals at hospital admission and already linked to an HIV clinic
* Medical, psychiatric or psychological condition that, in the opinion of the site investigator, would interfere with completion of study procedures
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute of Mental Health (NIMH)

NIH

Sponsor Role collaborator

Weill Medical College of Cornell University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Robert Peck, MD

Role: PRINCIPAL_INVESTIGATOR

Weill Medical College of Cornell University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Busisi Health Center

Busisi, Mwanza Region, Tanzania

Site Status

Magu District Hospital

Magu, Mwanza Region, Tanzania

Site Status

Nyamilama Health Center

Nyamilama, Mwanza Region, Tanzania

Site Status

Sengerema Health Center

Sengerema, Mwanza Region, Tanzania

Site Status

Bugando Medical Center

Mwanza, , Tanzania

Site Status

Bukumbi Hospital

Mwanza, , Tanzania

Site Status

Buzuruga Health Center

Mwanza, , Tanzania

Site Status

Evangelical Lutheran Church in Tanzania (ELCT) Health Centre

Mwanza, , Tanzania

Site Status

Igoma Health Centre

Mwanza, , Tanzania

Site Status

Karume Health Centre

Mwanza, , Tanzania

Site Status

Kwimba District Hospital

Mwanza, , Tanzania

Site Status

Misungwi District Hospital

Mwanza, , Tanzania

Site Status

Nyamagana District Hospital

Mwanza, , Tanzania

Site Status

Sekou Toure Hospital

Mwanza, , Tanzania

Site Status

Sengerema District Hospital

Mwanza, , Tanzania

Site Status

Seventh Day Adventist (SDA) Health Centre

Mwanza, , Tanzania

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Tanzania

References

Explore related publications, articles, or registry entries linked to this study.

Okello ES, Peck RN, Issarow B, Kisigo G, Abel K, Malibwa D, Kabakama S, Charles M, Lee M, Rutachunzibwa T, Fitzgerald D, Ayieko P, Grosskurth H, Metsch LR, Kapiga S. "Ashamed of being seen in an HIV clinic": a qualitative analysis of barriers to engaging in HIV care from the perspectives of patients and healthcare workers in the Daraja clinical trial. BMC Public Health. 2025 Jan 7;25(1):69. doi: 10.1186/s12889-024-21231-z.

Reference Type DERIVED
PMID: 39773172 (View on PubMed)

Peck RN, Issarow B, Kisigo GA, Kabakama S, Okello E, Rutachunzibwa T, Willkens M, Deogratias D, Hashim R, Grosskurth H, Fitzgerald DW, Ayieko P, Lee MH, Murphy SM, Metsch LR, Kapiga S. Linkage Case Management and Posthospitalization Outcomes in People With HIV: The Daraja Randomized Clinical Trial. JAMA. 2024 Mar 26;331(12):1025-1034. doi: 10.1001/jama.2024.2177.

Reference Type DERIVED
PMID: 38446792 (View on PubMed)

Kisigo GA, Issarow B, Abel K, Hashim R, Okello ES, Ayieko P, Lee MH, Grosskurth H, Fitzgerald D, Peck RN, Kapiga S. A social worker intervention to reduce post-hospital mortality in HIV-infected adults in Tanzania (Daraja): Study protocol for a randomized controlled trial. Contemp Clin Trials. 2022 Feb;113:106680. doi: 10.1016/j.cct.2022.106680. Epub 2022 Jan 13.

Reference Type DERIVED
PMID: 35032664 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01MH118107-01

Identifier Type: NIH

Identifier Source: secondary_id

View Link

1804019134

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.